Tue, December 10, 2024
[ Tue, Dec 10th 2024 ]: Kiplinger
Oracle Stock Is Sinking After Earnings. Here's Why
[ Tue, Dec 10th 2024 ]: 24/7 Wall St
Here's Why The Vanguard S&P 500 (VOO) Could Rocket to New Highs in 2025
[ Tue, Dec 10th 2024 ]: CNN
Argentina's Milei counts Trump and Musk as fans. Here's what his 'chainsaw approach' has delivered
[ Tue, Dec 10th 2024 ]: MSN
Dividend investors should put these 2 top ASX shares on their watchlist
[ Tue, Dec 10th 2024 ]: The Globe and Mail
No retirement savings in your 40s? Here's what to do now
[ Tue, Dec 10th 2024 ]: The Daily Telegraph
'It's hard to tell where inflation might strike, but one tobacco stock is up 40pc this year'
[ Tue, Dec 10th 2024 ]: Investopedia
Oracle Stock Slides as Revenue Falls Short of Expectations
[ Tue, Dec 10th 2024 ]: Yahoo Finance
BILL Holdings (BILL) is a Great Momentum Stock: Should You Buy?
[ Tue, Dec 10th 2024 ]: Wall Street Journal
Wall Street Is Betting Billions on Rental Homes as Ownership Slips Out of Reach
[ Tue, Dec 10th 2024 ]: The Motley Fool UK
3 ways to harness the wisdom of Warren Buffett when stock picking
[ Tue, Dec 10th 2024 ]: MSN
Prediction: Palantir Stock Will Soar After Dec. 13 (There's a Catch Though)
[ Tue, Dec 10th 2024 ]: esquiremag
Financial Adviser: 5 Low-Priced Value Stocks in 2 .. 's 'Net-Net' Strategy and How to Profit from Them
[ Tue, Dec 10th 2024 ]: The Motley Fool
Want Safe Dividend Income in 2025 and Beyond? Invest in the Following 2 Ultra-High-Yield Stocks.
[ Tue, Dec 10th 2024 ]: Seeking Alpha
VICI Properties: Why I Am Selling This Dividend Darling
[ Tue, Dec 10th 2024 ]: Seeking Alpha
Why Is Singapore Equity Attractive To Investors?
[ Tue, Dec 10th 2024 ]: AOL
Can You Invest in BlueSky Stock and Is It Worth It?
[ Tue, Dec 10th 2024 ]: Yahoo Finance
Shopify (SHOP) is a Great Momentum Stock: Should You Buy?
[ Tue, Dec 10th 2024 ]: The Motley Fool
3 Cruise Line Stocks to Buy Hand Over Fist in December
[ Tue, Dec 10th 2024 ]: The Motley Fool UK
Just released: December's higher-risk, high-reward stock recommendation [PREMIUM PICKS]
[ Tue, Dec 10th 2024 ]: The Motley Fool Canada
Earn $6,000 Tax-Free Annually With This TFSA Strategy
[ Tue, Dec 10th 2024 ]: The Daily Telegraph
This overlooked gem offers a fat yield while waiting for long-term growth
Mon, December 9, 2024
[ Mon, Dec 09th 2024 ]: Forbes
5 Best Undervalued Stocks To Buy In January 2025
[ Mon, Dec 09th 2024 ]: Fidelity International
Top 10: what investment trusts did investors buy in November?
[ Mon, Dec 09th 2024 ]: Yahoo Finance
Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
[ Mon, Dec 09th 2024 ]: NBC Washington
Jim Cramer reviews companies that cracked $100 billion in 2024
[ Mon, Dec 09th 2024 ]: Reuters
Wall Street closes down as tech stocks fall
[ Mon, Dec 09th 2024 ]: Motley Fool Australia
IAG shares slip as insurer faces second class action
[ Mon, Dec 09th 2024 ]: Forbes
Ways To Invest In Tesla Beyond Buying TSLA Stock
[ Mon, Dec 09th 2024 ]: Investopedia
Top Stock Movers Now: Nvidia, Hershey, Supermicro, and More
[ Mon, Dec 09th 2024 ]: Kiplinger
Stock Market Today: Markets Reflect Global Uncertainty
[ Mon, Dec 09th 2024 ]: The Motley Fool Canada
TFSA: 4 Canadian Stocks to Buy and Hold Forever
[ Mon, Dec 09th 2024 ]: Insider Monkey
Microchip Technology Incorporated (MCHP) Declined Due To Lower Than Expected Guidance
[ Mon, Dec 09th 2024 ]: Morningstar
The Best Companies to Own: 2025 Edition
[ Mon, Dec 09th 2024 ]: The Globe and Mail
Market Factors: A simple, effective tool for stock picking from Goldman Sachs
[ Mon, Dec 09th 2024 ]: Yahoo Finance
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
[ Mon, Dec 09th 2024 ]: The Motley Fool
Why Satellogic Stock Soared 24% Today
[ Mon, Dec 09th 2024 ]: Seeking Alpha
TH International: Caught In A Price War
[ Mon, Dec 09th 2024 ]: U.S. News & World Report
Boeing to Lay off Nearly 400 Employees in Washington State, WARN Notice Shows
[ Mon, Dec 09th 2024 ]: 24/7 Wall St
Stock Market Today: Nasdaq Composite and S&P 500 Fall While Applovin (APP) Plummets
[ Mon, Dec 09th 2024 ]: 24/7 Wall St
Stock Market Today: Nasdaq Composite and S&P 500 Flat While Applovin (APP) Plummets
[ Mon, Dec 09th 2024 ]: Business Insider
Stock market today: Rally stalls as Nvidia slips and investors await latest inflation data
[ Mon, Dec 09th 2024 ]: The Globe and Mail
An Investor's Guide to the Artificial Intelligence (AI) Value Chain
[ Mon, Dec 09th 2024 ]: MSN
Mixed Results And Lowered Revenue Outlook Dragged Elastic N.V. (ESTC) in Q3
[ Mon, Dec 09th 2024 ]: MSN
'Time to Turn Bullish,' Says Investor About SoundHound AI Stock
[ Mon, Dec 09th 2024 ]: El País in English
Five signs of market excesses: What dangers lurk beneath the record highs?
[ Mon, Dec 09th 2024 ]: The Motley Fool
Meet the Supercharged Growth Stock That Could Make You a Millionaire
[ Mon, Dec 09th 2024 ]: USA Today
Should you buy stocks before the new year? Here's what history says.
[ Mon, Dec 09th 2024 ]: MarketWatch
Wall Street has a new high bar for the S&P 500 in 2025. Here's what's driving that.

Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -therapeutics-halo-is-a-strong-growth-stock.html
  Print publication without navigation Published in Stocks and Investing on by Yahoo Finance
          🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
The article from Yahoo Finance discusses why Halozyme Therapeutics (HALO) stock has experienced a significant increase in value. It highlights that the company's stock surged after announcing a new royalty deal with the pharmaceutical company, Argenx. This deal involves the use of Halozyme's proprietary ENHANZE® drug delivery technology, which enhances the subcutaneous administration of biologics, potentially speeding up the delivery and improving patient convenience. The agreement not only validates Halozyme's technology but also promises to bring in substantial future revenue through royalties, boosting investor confidence. Additionally, the article mentions that Halozyme has been expanding its partnerships, which further supports its growth narrative. The positive market reaction is also attributed to the broader market's optimism about biologics and innovative drug delivery systems.

Read the Full YAHOO!Finance Article at:
[ https://finance.yahoo.com/news/heres-why-halozyme-therapeutics-halo-144510596.html ]